Maven Securities LTD Y M Abs Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$15.51 - $29.31 $756,252 - $1.43 Million
-48,759 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$27.47 - $37.31 $1.48 Million - $2.02 Million
-54,041 Reduced 52.57%
48,759 $1.39 Million
Q2 2021

Aug 16, 2021
BUY
$25.45 - $37.64 $962,010 - $1.42 Million
37,800 Added 58.15%
102,800 $3.52 Million
Q1 2021

May 17, 2021
BUY
$29.16 - $51.96 $1.9 Million - $3.38 Million
65,000 New
65,000 $1.9 Million

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $487M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email